AstraZeneca AZN.L on Friday said it was prioritizing the U.S. market for additional doses of its respiratory syncytial virus (RSV) drug Beyfortus.
911 News Blogger Template is Designed Theme for Giving Enhanced look Various Features are available Which is designed in User friendly to handle by Piki Developers. Simple and elegant themes for making it more comfortable